Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Changxi Pharmaceutical
Hangzhou, Zhejiang, Chinachancepharmaceuticals.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Hangzhou Changxi Pharmaceutical (“Chance Pharma”) is a clinical-stage biotechnology company specializing in innovative dry powder inhalation therapies. Its lead asset CXG87—an improved budesonide/formoterol DPI—is currently in Phase III trials. The company leverages proprietary spray drying and particle engineering platforms to develop both generic and novel therapeutics targeting major respiratory diseases such as asthma and COPD, as well as CNS disorders. The firm has demonstrated strong R&D capabilities with multiple assets advancing through the clinic supported by recent funding rounds.
- Therapeutic areas
- PulmonologyCardiovascularNeurology
- Modalities
- Small moleculeNanobody therapyMonoclonal antibody
- Industry
- Biotech
02
Partnerships
Shijiazhuang Yiling Pharmaceutical
Beyond the preview
Go deeper on Hangzhou Changxi Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hangzhou Changxi Pharmaceutical.